Tech Company Financing Transactions
Kerecis Funding Round
On 8/2/2022, Kerecis landed $100 million in funding from Kirkbi, Bru Pension Fund and Emerson Collective.
Transaction Overview
Company Name
Announced On
8/2/2022
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate growth and development of the next generations of its patented medical-fish-skin products sourced from sustainable fishing grounds near the Arctic Circle.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
2300 Clarendon Blvd, Suite 1210
Arlington, VA 22201
USA
Arlington, VA 22201
USA
Phone
Website
Email Address
Overview
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company's patented technologies protect the body's own tissues and enable the body to regenerate tissues. Developed and manufactured in Isafjordur, Iceland, Kerecis medical products are authorized for sale in Europe, the United States. and several other jurisdictions for human-tissue repair. Thousands of patients are treated annually with our technology. And we are broadening our product line to address many more types of soft-tissue damage.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/2/2022: MarqVision venture capital transaction
Next: 8/2/2022: Hysata venture capital transaction
Share this article
About Our VC Transactions Data
We record funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs